PROK
PROKIDNEY CORP.
NASDAQ · Healthcare · Biotechnology · US
$1.32
−10.54%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 260.81x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -0.31x
- Price / sales
- 335.87x
- Price / cash flow
- -1.95x
Enterprise value
- Enterprise value
- $1.2B
- EV / sales
- 1470.74x
- EV / EBITDA
- -7.52x
- EV / EBIT
- -6.79x
- Market cap
- $274.7M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026